Company / Cash & Equivalents
CRYO CELL INTERNATIONAL INC Cash & Equivalents History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$4.2M
FY2017
5-year range
$2.7M / $4.2M
FY2013-FY2017
Trend
+0.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $4M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2017 with a 5-year CAGR of -8.0%.
Improved from $4M to $4M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -8.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.0%, indicating a declining trend.
- In FY2017, cash & equivalents increased 0.0% year-over-year.
- Peak cash & equivalents was recorded in FY2011.
- Lowest cash & equivalents in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $4.2M | +0.0% |
| FY2016 | $4.2M | +5.8% |
| FY2015 | $3.9M | +0.0% |
| FY2014 | $3.9M | +46.6% |
| FY2013 | $2.7M | -57.5% |
| FY2012 | $6.3M | -24.7% |
| FY2011 | $8.4M | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026